<p>Lazard Asset Management LLC 在最近向證券交易委員會的披露中表示，在第二季度將其在直覺外科公司（NASDAQ:ISRG - 免費報告）股票中的持倉增加了 0.4%。該基金在此期間購買了 2,267 股後，持有 589,109 股該醫療設備提供商的股票。截至最近一個季度末，Lazard Asset Management LLC 持有直覺外科 0.16% 的股份，價值 320,126,000 美元。</p>
<p>獲取 <strong>Intuitive Surgical</strong> 警報：</p>
<ul>
<li>1.34 億美元的內部交易：這對 KMI、ISRG 和 QS 可能意味着什麼</li>
</ul>
<p>其他幾家機構投資者和對沖基金最近也買賣了 ISRG 的股票。Tobam 在第二季度將其在直覺外科的持股增加了 666.7%。Tobam 目前持有 46 股該醫療設備提供商的股票，價值 25,000 美元，此前在上個季度又購買了 40 股。Kilter Group LLC 在第二季度購買了直覺外科的新頭寸，價值約 27,000 美元。TD Capital Management LLC 在第一季度將其在直覺外科的持倉增加了 300.0%。TD Capital Management LLC 目前持有 60 股該醫療設備提供商的股票，價值 30,000 美元，此前在此期間又收購了 45 股。1248 Management LLC 在第一季度收購了直覺外科的新股份，價值 30,000 美元。最後，Princeton Global Asset Management LLC 在第二季度購買了直覺外科的新股份，價值 30,000 美元。目前 83.64% 的股票由機構投資者和對沖基金持有。</p>
<h2>直覺外科的內部買賣</h2>
<p>在其他直覺外科的新聞中，董事 Craig H. Barratt 在 11 月 12 日（星期三）出售了 750 股公司的股票。該股票以 580.00 美元的平均價格出售，總交易額為 435,000.00 美元。此次出售在向 SEC 的文件中披露，相關信息可在 SEC 網站上獲取。此外，執行副總裁 Myriam Curet 在 12 月 10 日（星期三）出售了 104 股該股票。該股票以 559.90 美元的平均價格出售，總價值為 58,229.60 美元。此次出售的 SEC 文件提供了更多信息。在過去的九十天裏，內部人士已出售 109,043 股公司股票，價值 60,816,225 美元。內部人士持有公司 0.70% 的股份。</p>
<h2>分析師設定新目標價</h2>
<ul>
<li>通過特朗普關税政策的三大股票</li>
</ul>
<p>一些股票分析師最近對 ISRG 股票進行了評估。瑞銀集團在 10 月 23 日（星期四）設定了直覺外科 600.00 美元的目標價，並給予該股票 “中性” 評級。大和資本市場在 10 月 24 日（星期五）將直覺外科的目標價從 510.00 美元上調至 550.00 美元，並給予該公司 “跑贏大盤” 評級。華爾街 Zen 在 12 月 6 日（星期六）將直覺外科的評級從 “買入” 下調至 “持有”。Piper Sandler 在 10 月 22 日（星期三）將直覺外科的目標價從 595.00 美元上調至 610.00 美元，並給予該公司 “增持” 評級。最後，BTIG 研究在 10 月 22 日（星期三）將直覺外科的目標價從 529.00 美元上調至 589.00 美元，並給予該股票 “買入” 評級。兩位投資分析師對該股票給予了強烈買入評級，十六位給予買入評級，八位給予持有評級，一位給予賣出評級。根據 MarketBeat 的數據，該公司目前的共識評級為 “適度買入”，共識目標價為 608.79 美元。</p>
<p><strong>閲讀我們最新的 ISRG 股票分析</strong></p>
<h2>直覺外科股票表現</h2>
<ul>
<li>為什麼直覺外科對長期投資者來説是個明智的選擇</li>
</ul>
<p>ISRG 的股票在週五開盤價為 542.32 美元。該公司的 50 日簡單移動平均線為 529.62 美元，200 日簡單移動平均線為 506.00 美元。直覺外科公司一年的最低價為 425.00 美元，最高價為 616.00 美元。該股票的市值為 1944.1 億美元，市盈率為 71.74，市盈增長比率為 5.03，貝塔值為 1.68。</p>
<p>直覺外科（NASDAQ:ISRG - 獲取免費報告）最近在 10 月 21 日（星期二）公佈了其財報。該醫療設備提供商報告本季度每股收益為 2.40 美元，超出市場共識預期的 1.99 美元，超出幅度為 0.41 美元。該公司本季度的收入為 25.1 億美元，而市場共識預期為 24.1 億美元。直覺外科的淨利潤率為 28.58%，股本回報率為 15.08%。該公司本季度的收入同比增長 22.9%。在去年同期，該公司每股收益為 1.84 美元。根據賣方分析師的預測，直覺外科公司預計今年每股收益為 6.43 美元。</p>
<h2>直覺外科公司簡介</h2>
<p>（免費報告）</p>
<p>直覺外科公司開發、製造和銷售產品，使醫生和醫療服務提供者能夠提高美國及國際上微創護理的質量和可及性。該公司提供達芬奇手術系統，能夠以微創方式進行復雜手術；以及 Ion 內腔系統，擴展其商業產品範圍，涵蓋微創肺活檢的診斷程序。</p>
<h2>閲讀更多</h2>
<ul>
<li>五隻我們更看好的股票超過直覺外科</li>
<li>成長投資：您應該在 2022 年採用這種投資策略嗎？</li>
<li>為什麼亞馬遜可能在幾周內成為 300 美元的股票</li>
<li>哪裏可以找到財報電話會議記錄</li>
<li>Adobe 在財報後獲得提振：長期前景看好</li>
<li>期權交易 - 理解行使價格</li>
<li>MarketBeat 週迴顧 – 12/8 - 12/12</li>
</ul>
<p><strong>想知道其他對沖基金持有 ISRG 的情況嗎？</strong> 訪問 HoldingsChannel.com 獲取 Intuitive Surgical, Inc. (NASDAQ:ISRG - 免費報告) 的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Intuitive Surgical 嗎？</h2>
<p>在考慮 Intuitive Surgical 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而 Intuitive Surgical 並不在名單上。</p>
<p>雖然 Intuitive Surgical 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

直覺外科

<p>Lazard Asset Management LLC 在第二季度將其在直覺外科公司的股份增加了 0.4%，目前持有 589,109 股，價值 3.2013 億美元。其他機構投資者也調整了他們的持倉。內部人士在過去 90 天內出售了 109,043 股，價值 6082 萬美元。分析師對 ISRG 的評級褒貶不一，普遍評級為 “適度買入”，目標價為 608.79 美元。直覺外科公司的第三季度收益超出預期，收入為 25.1 億美元，每股收益為 2.40 美元</p>

<p>Lazard Asset Management LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 589,109 shares of the medical equipment provider's stock after purchasing an additional 2,267 shares during the period. Lazard Asset Management LLC owned 0.16% of Intuitive Surgical worth $320,126,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Lazard Asset Management LLC 在最近向證券交易委員會的披露中表示，在第二季度將其在直覺外科公司（NASDAQ:ISRG - 免費報告）股票中的持倉增加了 0.4%。該基金在此期間購買了 2,267 股後，持有 589,109 股該醫療設備提供商的股票。截至最近一個季度末，Lazard Asset Management LLC 持有直覺外科 0.16% 的股份，價值 320,126,000 美元。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Intuitive Surgical</strong> 警報：</p>
</div><ul>
<li>$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS</li>
</ul>
<div class="lb-trans"><ul>
<li>1.34 億美元的內部交易：這對 KMI、ISRG 和 QS 可能意味着什麼</li>
</ul>
</div><p>Several other institutional investors and hedge funds also recently bought and sold shares of ISRG. Tobam increased its holdings in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider's stock worth $25,000 after buying an additional 40 shares during the last quarter. Kilter Group LLC purchased a new position in Intuitive Surgical in the second quarter worth approximately $27,000. TD Capital Management LLC grew its position in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 45 shares during the period. 1248 Management LLC acquired a new stake in Intuitive Surgical during the first quarter worth $30,000. Finally, Princeton Global Asset Management LLC purchased a new stake in Intuitive Surgical in the second quarter valued at $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他幾家機構投資者和對沖基金最近也買賣了 ISRG 的股票。Tobam 在第二季度將其在直覺外科的持股增加了 666.7%。Tobam 目前持有 46 股該醫療設備提供商的股票，價值 25,000 美元，此前在上個季度又購買了 40 股。Kilter Group LLC 在第二季度購買了直覺外科的新頭寸，價值約 27,000 美元。TD Capital Management LLC 在第一季度將其在直覺外科的持倉增加了 300.0%。TD Capital Management LLC 目前持有 60 股該醫療設備提供商的股票，價值 30,000 美元，此前在此期間又收購了 45 股。1248 Management LLC 在第一季度收購了直覺外科的新股份，價值 30,000 美元。最後，Princeton Global Asset Management LLC 在第二季度購買了直覺外科的新股份，價值 30,000 美元。目前 83.64% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Insider Buying and Selling at Intuitive Surgical</h2>
<div class="lb-trans"><h2>直覺外科的內部買賣</h2>
</div><p>In other Intuitive Surgical news, Director Craig H. Barratt sold 750 shares of the company's stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $435,000.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Myriam Curet sold 104 shares of the stock in a transaction dated Wednesday, December 10th. The shares were sold at an average price of $559.90, for a total value of $58,229.60. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 109,043 shares of company stock valued at $60,816,225. Insiders own 0.70% of the company's stock.</p>
<div class="lb-trans"><p>在其他直覺外科的新聞中，董事 Craig H. Barratt 在 11 月 12 日（星期三）出售了 750 股公司的股票。該股票以 580.00 美元的平均價格出售，總交易額為 435,000.00 美元。此次出售在向 SEC 的文件中披露，相關信息可在 SEC 網站上獲取。此外，執行副總裁 Myriam Curet 在 12 月 10 日（星期三）出售了 104 股該股票。該股票以 559.90 美元的平均價格出售，總價值為 58,229.60 美元。此次出售的 SEC 文件提供了更多信息。在過去的九十天裏，內部人士已出售 109,043 股公司股票，價值 60,816,225 美元。內部人士持有公司 0.70% 的股份。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><ul>
<li>Top 3 Stocks Powering Through Trump’s Tariff Policies</li>
</ul>
<div class="lb-trans"><ul>
<li>通過特朗普關税政策的三大股票</li>
</ul>
</div><p>A number of equities analysts have recently weighed in on ISRG shares. UBS Group set a $600.00 price target on Intuitive Surgical and gave the stock a &#34;neutral&#34; rating in a report on Thursday, October 23rd. Daiwa Capital Markets upped their target price on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an &#34;outperform&#34; rating in a research report on Friday, October 24th. Wall Street Zen lowered shares of Intuitive Surgical from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, December 6th. Piper Sandler lifted their price target on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday, October 22nd. Finally, BTIG Research upped their price objective on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a &#34;buy&#34; rating in a report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $608.79.</p>
<div class="lb-trans"><p>一些股票分析師最近對 ISRG 股票進行了評估。瑞銀集團在 10 月 23 日（星期四）設定了直覺外科 600.00 美元的目標價，並給予該股票 “中性” 評級。大和資本市場在 10 月 24 日（星期五）將直覺外科的目標價從 510.00 美元上調至 550.00 美元，並給予該公司 “跑贏大盤” 評級。華爾街 Zen 在 12 月 6 日（星期六）將直覺外科的評級從 “買入” 下調至 “持有”。Piper Sandler 在 10 月 22 日（星期三）將直覺外科的目標價從 595.00 美元上調至 610.00 美元，並給予該公司 “增持” 評級。最後，BTIG 研究在 10 月 22 日（星期三）將直覺外科的目標價從 529.00 美元上調至 589.00 美元，並給予該股票 “買入” 評級。兩位投資分析師對該股票給予了強烈買入評級，十六位給予買入評級，八位給予持有評級，一位給予賣出評級。根據 MarketBeat 的數據，該公司目前的共識評級為 “適度買入”，共識目標價為 608.79 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on ISRG</strong></p>
<div class="lb-trans"><p><strong>閲讀我們最新的 ISRG 股票分析</strong></p>
</div><h2>Intuitive Surgical Stock Performance</h2>
<div class="lb-trans"><h2>直覺外科股票表現</h2>
</div><ul>
<li>Why Intuitive Surgical Is a No-Brainer for Long-Term Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>為什麼直覺外科對長期投資者來説是個明智的選擇</li>
</ul>
</div><p>Shares of ISRG opened at $542.32 on Friday. The company's 50-day simple moving average is $529.62 and its 200-day simple moving average is $506.00. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The stock has a market capitalization of $194.41 billion, a PE ratio of 71.74, a P/E/G ratio of 5.03 and a beta of 1.68.</p>
<div class="lb-trans"><p>ISRG 的股票在週五開盤價為 542.32 美元。該公司的 50 日簡單移動平均線為 529.62 美元，200 日簡單移動平均線為 506.00 美元。直覺外科公司一年的最低價為 425.00 美元，最高價為 616.00 美元。該股票的市值為 1944.1 億美元，市盈率為 71.74，市盈增長比率為 5.03，貝塔值為 1.68。</p>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm's revenue for the quarter was up 22.9% on a year-over-year basis. During the same period in the prior year, the firm earned $1.84 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.</p>
<div class="lb-trans"><p>直覺外科（NASDAQ:ISRG - 獲取免費報告）最近在 10 月 21 日（星期二）公佈了其財報。該醫療設備提供商報告本季度每股收益為 2.40 美元，超出市場共識預期的 1.99 美元，超出幅度為 0.41 美元。該公司本季度的收入為 25.1 億美元，而市場共識預期為 24.1 億美元。直覺外科的淨利潤率為 28.58%，股本回報率為 15.08%。該公司本季度的收入同比增長 22.9%。在去年同期，該公司每股收益為 1.84 美元。根據賣方分析師的預測，直覺外科公司預計今年每股收益為 6.43 美元。</p>
</div><h2>Intuitive Surgical Company Profile</h2>
<div class="lb-trans"><h2>直覺外科公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.</p>
<div class="lb-trans"><p>直覺外科公司開發、製造和銷售產品，使醫生和醫療服務提供者能夠提高美國及國際上微創護理的質量和可及性。該公司提供達芬奇手術系統，能夠以微創方式進行復雜手術；以及 Ion 內腔系統，擴展其商業產品範圍，涵蓋微創肺活檢的診斷程序。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>閲讀更多</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>Growth Investing: Should You Adopt This Investing Strategy in 2022?</li>
<li>Why Amazon Could Be a $300 Stock Within Weeks</li>
<li>Where to Find Earnings Call Transcripts</li>
<li>Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside</li>
<li>Options Trading - Understanding Strike Price</li>
<li>MarketBeat Week in Review – 12/8 - 12/12</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過直覺外科</li>
<li>成長投資：您應該在 2022 年採用這種投資策略嗎？</li>
<li>為什麼亞馬遜可能在幾周內成為 300 美元的股票</li>
<li>哪裏可以找到財報電話會議記錄</li>
<li>Adobe 在財報後獲得提振：長期前景看好</li>
<li>期權交易 - 理解行使價格</li>
<li>MarketBeat 週迴顧 – 12/8 - 12/12</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ISRG?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他對沖基金持有 ISRG 的情況嗎？</strong> 訪問 HoldingsChannel.com 獲取 Intuitive Surgical, Inc. (NASDAQ:ISRG - 免費報告) 的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Intuitive Surgical 嗎？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Intuitive Surgical 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場注意到之前立即購買……而 Intuitive Surgical 並不在名單上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Intuitive Surgical 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Lazard Asset Management LLC 增加了對直覺外科公司（Intuitive Surgical, Inc.）股票的持有量 $ISRG